Delivery Order SPE2DB20D1100-SPE2DB24FB2K9

Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The $2,757.00 firm fixed price delivery order is for the pharmaceutical product Calcipotriene 0.005% Solution 60ML. Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This award is part of an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,524.40 firm fixed-price delivery order is for the supply of Calcipotriene 0.005% Solution, a medical product, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,738.26, is for the supply of 60ml bottles of Calcipotriene 0.005% solution, a topical medication used in the treatment of psoriasis. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,135.24 firm fixed-price delivery order is for the supply of CALCIPOTRIENE 0.005% SOLUTION 60ML, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,111.00 firm fixed-price delivery order contract is for the supply of Calcipotriene 0.005% Cream, a dermatological medication, to support military healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,294.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Calcipotriene 0.005% solution (60ml). This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,487.84 firm fixed-price delivery order is for the supply of Calcipotriene 0.005% Solution, a topical medication. The contract has an ultimate completion date of April 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.34 firm fixed-price contract is for the delivery of Calcipotriene 0.005% Cream, a specialty medication, with a performance period ending on January 3, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Calcipotriene 0.005% Cream 60GM to the Defense Logistics Agency (DLA). The $1,078.78 Firm Fixed Price delivery order was issued under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV8KD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,598.92 firm fixed-price delivery order is for the supply of Calcipotriene 0.005% Cream, a topical medication, to support federal healthcare programs. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB2K9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $2,337.63 firm fixed price delivery order is for the supply of 60 ml bottles of the topical medication calcipotriene 0.005% solution. The award is not associated with any set-aside designation.

This delivery order is part of a larger, single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. Under this IDC, AmerisourceBergen Drug Corp serves as the prime contractor, providing a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense worldwide.

Generated 7/12/24, 10:02 AM